Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 163
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
GUEST EDITORIAL
Year : 2018  |  Volume : 66  |  Issue : 2  |  Page : 187-188

Diabetic retinopathy screening: Telemedicine, the way to go!


Consultant Vitreoretina Surgeon, North Cumbria University Hospitals NHS Trust, CA2 7PH, UK

Date of Web Publication30-Jan-2018

Correspondence Address:
Salil Sharad Gadkari
Consultant Vitreoretina Surgeon, North Cumbria University Hospitals NHS Trust, CA2 7PH
UK
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_1155_17

Rights and Permissions

How to cite this article:
Gadkari SS. Diabetic retinopathy screening: Telemedicine, the way to go!. Indian J Ophthalmol 2018;66:187-8

How to cite this URL:
Gadkari SS. Diabetic retinopathy screening: Telemedicine, the way to go!. Indian J Ophthalmol [serial online] 2018 [cited 2018 Nov 17];66:187-8. Available from: http://www.ijo.in/text.asp?2018/66/2/187/224068



India is considered to be the diabetes capital of the world with a diabetic population which is predicted to hit 69.9 million by 2025.[1] All professional eye-care organizations advocate annual eye examinations for patients with diabetes.[2] Screening over 12% of India's population, distributed over a subcontinent is not easy. A nationwide cross-sectional study of diabetic patients by the AIOS for the first time in 2014 for diabetic retinopathy (DR), reiterated the findings of earlier regional studies, with a prevalence at 21.7% on a pan Indian scale.[3]

The United Kingdom runs the world's largest public health program for screening of DR.[4],[5] There were 2.02 million people (aged 12 or over) who received diabetic screening, at an uptake rate of 82.5% out of which 67,001 were ungradeable and 56,913 needed further evaluation and treatment.[5] With a few assumptions, the annual running budget was £3.2 million without including the capital investment. Needless to say, this is not scalable to the Indian scenario which in comparison is gargantuan geographically and demographically. This compels us to look for other options, various models of which have been espoused in the recent years. All mass screening and awareness programs are a “trade off” between providing the gold standard for restricted numbers and doing something acceptably short of this for a much larger population.

The study published in this issue by Rani et al. throws light on a rural DR screening model using an indigenous camera.[6] This nonmydriatic fundus photography model was able to detect referable posterior segment abnormalities in a rural diabetes eye care program. All images were graded by a trained validated optometrist, 5% of random images being revalidated by the retina specialist. The optometrist and retina specialist had negligible interobserver variation (K = 0.932). Retinopathy was noted in almost 9% of the diabetics screened. Thirty-four percent were ungradeable images. This was mainly due to cataract and pupillary size.

Telemedicine using retinal photography and remote readers seems to be the mantra. Retinal photography allows permanent documentation of the retinopathy status and lends itself to remote reporting, quality control, and serial evaluation. Disruptive technologies in camera, software, and the cellular network have impacted the life of the common man through handheld devices; the spins offs of which have been a boon to diabetic screening models.[7] The large van with a regular Fundus camera, diesel generator, and an overhead dish antenna seems archaic in just over a decade. The components of a telemedicine model of DR screening are as follows: The camera and acquisition of gradable images, transmission of images securely to a reader, and finally reporting. The retinal camera should ideally be portable (in the true sense), battery operated, and take good quality retinal images. It should possess a system to archive and transmit data confidentially.[7],[8] Image resolution and the field photographed are again important parameters. Which option: a single 45° field centered on fovea, two 45° fields (centered on disc and fovea), or 7 ETDRS fields should be preferred? More time is required to acquire more images per patient. The future lies in a single wide-field picture that covers a 90°–100° field. Better the resolution of the image heavier the file. Studies have shown a 100 kb image is acceptable. The gradeability of images is an important issue often hampered by a small mesopic pupillary size in the tropics along with nuclear sclerosis. In our model, we dilated all eyes except those with a white to the white diameter of <11 mm or one-eyed patients. The risk of mydriatic-induced angle closure is overestimated.[9] Once acquired, the images then need to be transmitted to a reading center and graded. Whether the reader should be an ophthalmologist or technician is a subject for debate. Training and regular protocol of revalidation of reporting skills of readers is the most important factor for ensuring reliable reporting. Medicolegal issues can surround the use of technicians unless they work under the supervision of an ophthalmologist. Artificial intelligence is likely to play an important role in the detection of retinopathy in acquired images. The other issue of grading revolves around how we plan to use the screening method. Do we merely classify as presence/absence of DR warranting examination by an ophthalmologist or do we plan to grade and follow-up patients with retinopathy with telemedicine till such time as annual checks show progression to a certain threshold of disease or poor visualization due to developing a cataract.

An indigenous palmtop size device with a nonmydriatic 90°–100° field which can link to cloud is expected to create a paradigm shift shortly. Telemedicine programs by individual practices, NGO and the national program for control of blindness hold the key to adequate uptake of DR screening in India.



 
  References Top

1.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.  Back to cited text no. 1
[PUBMED]    
2.
American Academy of Ophthalmology. Diabetic Retinopathy Summary Benchmarks for Preferred Practice Pattern Guidelines. American Academy of Ophthalmology; 2014.  Back to cited text no. 2
    
3.
Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: The all India ophthalmological society diabetic retinopathy eye screening study 2014. Indian J Ophthalmol 2016;64:38-44.  Back to cited text no. 3
[PUBMED]  [Full text]  
4.
Essential Elements in Developing a Diabetic Retinopathy Screening Program (Workbook 4.3). U.K: National Screening Committee, Public Health England, UK; 2009.  Back to cited text no. 4
    
5.
Diabetic Eye Screening: Data Summary, 01 April, 2015 to 31 March, 2016. Public Health England Publications Gateway Number; 2016.  Back to cited text no. 5
    
6.
Rani PK, Bhattarai Y, Sheeladevi S, ShivaVaishnavi K, Ali MH, Babu JG. Analysis of yield of retinal imaging in a rural diabetes eye care model. Indian J Ophthalmol 2018;66:233-7.  Back to cited text no. 6
  [Full text]  
7.
Gadkari S. Innovative model for telemedicine-based screening for diabetic retinopathy in the developing world. Can J Ophthalmol 2016;51:e109-11.  Back to cited text no. 7
[PUBMED]    
8.
Gadkari SS. The Pune diabetic retinopathy awareness and screening model. J Clin Ophthalmol Res 2015;3:23-6.  Back to cited text no. 8
  [Full text]  
9.
Pandit RJ, Taylor R. Mydriasis and glaucoma: Exploding the myth. A systematic review. Diabet Med 2000;17:693-9.  Back to cited text no. 9
[PUBMED]    

 
  Authors Top


Dr Salil Gadkari is a Vitreoretina surgeon of over 25 years standing. He is presently on a sabbatical in the UK as Consultant Ophthalmologist and head of Vitreoretina services at the North Cumbria University Hospitals NHS Trust. He has served as Head of Vitreoretina service and subsequently Research Director at HV Desai Eye Hospital, Pune for over 12 years. Passionate about Diabetic retinopathy screening using telemedicine, his "Pune Model" was well acknowledged. Dr Gadkari is known internationally for his published work on ROP Surgery. He is a past president and past scientific committee chairman of the Maharashtra Ophthalmological Society and an editorial board member of the IJO.




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References
Authors

 Article Access Statistics
    Viewed977    
    Printed9    
    Emailed0    
    PDF Downloaded269    
    Comments [Add]    

Recommend this journal